IQV
IQVIA Holdings IncNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$30.60B
P/E Ratio
22.77
EPS
$8.05
Beta
1.22
52W High
$247.05
52W Low
$153.01
50-Day MA
$171.93
200-Day MA
$195.70
Dividend Yield
—
Profit Margin
8.33%
Forward P/E
14.56
PEG Ratio
0.75
About IQVIA Holdings Inc
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Fundamentals
| Revenue (TTM) | $16.63B |
| Gross Profit (TTM) | $5.49B |
| EBITDA | $3.00B |
| Operating Margin | 13.60% |
| Return on Equity | 22.50% |
| Return on Assets | 5.13% |
| Revenue/Share (TTM) | $97.79 |
| Book Value | $37.27 |
| Price-to-Book | 5.00 |
| Price-to-Sales (TTM) | 1.84 |
| EV/Revenue | 2.708 |
| EV/EBITDA | 12.80 |
| Quarterly Earnings Growth (YoY) | 15.00% |
| Quarterly Revenue Growth (YoY) | 8.40% |
| Shares Outstanding | $166.90M |
| Float | $158.55M |
| % Insiders | 1.08% |
| % Institutions | 103.53% |
Historical Volatility
HV 10-Day
54.57%
HV 20-Day
44.06%
HV 30-Day
46.01%
HV 60-Day
41.76%
HV Rank
71.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($228.10 target)
4
Strong Buy17
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 6/11/2026